|
Market Cap (3-Jul) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
CPH released this announcement to the ASX on 19 October 2022, 19:10. The announcement is not marked as price sensitive, and is 10 page(s) in length and 31.49kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.143% short sold according to ASIC data. It was ranked the 448th most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| Application for quotation of securities - CPH | 19 October 2022, 19:10 |
| Final Director's Interest Notice | 17 October 2022, 18:55 |
| Initial Director's Interest Notice x2 | 14 October 2022, 19:40 |
| Sierra Sage enters into agreement with accelerate360 | 13 October 2022, 10:03 |
You must be logged in to post a reply.
Creso Pharma 